Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease
Authors
Keywords
Endogenous ligands, Innate immunity, Spondyloarthropathy, TLR4
Journal
CLINICAL RHEUMATOLOGY
Volume 35, Issue 12, Pages 3075-3079
Publisher
Springer Nature
Online
2016-10-13
DOI
10.1007/s10067-016-3448-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myeloid-related Protein 8/14 Levels in Rheumatoid Arthritis: Marker of Disease Activity and Response to Methotrexate
- (2016) P. S. Patro et al. JOURNAL OF RHEUMATOLOGY
- Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis
- (2015) H Cypers et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of the unfolded protein response in axial spondyloarthritis
- (2015) Judith A. Smith CLINICAL RHEUMATOLOGY
- Tenascin-C Levels, A Toll-like Receptor 4 Ligand, in Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis: A Cross-sectional and Longitudinal Study
- (2015) A. Shukla et al. JOURNAL OF RHEUMATOLOGY
- Elevated Serum Levels of Calprotectin (Myeloid-Related Protein 8/14) in Patients With Ankylosing Spondylitis and Its Association With Disease Activity and Quality of Life
- (2015) Pelin Oktayoglu et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis
- (2014) Maureen C Turina et al. ARTHRITIS RESEARCH & THERAPY
- S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
- (2014) Claes Hansson et al. Journal of Immunology Research
- Molecular and Cellular Regulation of Toll-Like Receptor-4 Activity Induced by Lipopolysaccharide Ligands
- (2014) Ardiyanto Liaunardy-Jopeace et al. Frontiers in Immunology
- MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis
- (2013) Ivy Y Choi et al. ANNALS OF THE RHEUMATIC DISEASES
- Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study
- (2013) Sofia Ramiro et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Mechanistic biomarkers for clinical decision making in rheumatic diseases
- (2013) William H. Robinson et al. Nature Reviews Rheumatology
- TLR4 endogenous ligand MRP8/14 level in enthesitis-related arthritis and its association with disease activity and TLR4 expression
- (2013) M. T. Rahman et al. RHEUMATOLOGY
- Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum
- (2012) Eva Klingberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response
- (2011) Ling Zeng et al. ARTHRITIS AND RHEUMATISM
- Classification criteria for psoriatic arthritis and ankylosing spondylitis/axial spondyloarthritis
- (2010) Martin Rudwaleit et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor inhibitors
- (2009) S. J. Pedersen et al. ANNALS OF THE RHEUMATIC DISEASES
- ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis
- (2008) D van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now